Review on genetic variants and maternal smoking in the etiology of oral clefts and other birth defects

Birth Defects Research Part C - Embryo Today: Reviews

Volumn 84, Issue 1, 2008, Pages 16-29

  Shi, Min ^a   Wehby, George L ^b   Murray, Jeffrey C ^c  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c UNIVERSITY OF IOWA   (United States)

Author keywords

Birth defects; Cleft lip; Cleft palate; Gene environment interaction; Smoking

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; 5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); AROMATIC HYDROCARBON RECEPTOR; CYTOCHROME P450 1A1; ENDOTHELIAL NITRIC OXIDE SYNTHASE; EPOXIDE HYDROLASE; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE T1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 1BETA; PROTEIN BCL 3; RETINOIC ACID RECEPTOR ALPHA; SULFOTRANSFERASE 1A1; TRANSCRIPTION FACTOR MSX1; TRANSFORMING GROWTH FACTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA3;

BIRTH DEFECT; CLEFT LIP; CLEFT PALATE; CONGENITAL HEART DISEASE; DETOXIFICATION; DOWN SYNDROME; EMBRYO DEVELOPMENT; GASTROSCHISIS; GENETIC VARIABILITY; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; LIMB DEFECT; LOW BIRTH WEIGHT; MATERNAL SMOKING; NEURAL TUBE DEFECT; PREGNANCY OUTCOME; PREMATURITY; PRIORITY JOURNAL; REVIEW; XENOBIOTIC METABOLISM;

CLEFT LIP; CONGENITAL ABNORMALITIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MATERNAL EXPOSURE; PREGNANCY; PREGNANCY COMPLICATIONS; SMOKING; VARIATION (GENETICS);

EID: 41849129433     PISSN: 1542975X     EISSN: None     Source Type: Journal    
DOI: 10.1002/bdrc.20117     Document Type: Review

References (123)

1. Alappat S, Zhang ZY, Chen YP. 2003. Msx homeobox gene family and craniofacial development. Cell Res 13:429-442.
2. Alderman BW, Bradley CM, Greene C, et al. 1994. Increased risk of craniosynostosis with maternal cigarette smoking during pregnancy. Teratology 50:13-18.
3. Alvarez SM, Burd RS. 2007. Increasing prevalence of gastroschis repairs in the United States: 1996-2003. J Pediatr Surg 42:943-946.
4. Ardinger HH, Buetow KH, Bell GI, et al. 1989. Association of genetic variation of the transforming growth factor-alpha gene with cleft lip and palate. Am J Hum Genet 45:348-353.
5. Beaty TH, Hetmanski JB, Zeiger JS, et al. 2002. Testing candidate genes for non-syndromic oral clefts using a case-parent trio design. Genet Epidemiol 22:1-11.
6. Beaty TH, Maestri NE, Hetmanski JB, et al. 1997. Testing for interaction between maternal smoking and TGFA genotype among oral cleft cases born in Maryland 1992-1996. Cleft Palate Craniofac J 34:447-454.
7. Bille C, Knudsen LB, Christensen K. 2005. Changing lifestyles and oral clefts occurrence in Denmark. Cleft Palate Craniofac J 42:255-259.
8. Bille C, Olsen J, Vach W, et al. 2007. Oral clefts and life style factors - a case-cohort study based on prospective Danish data. Eur J Epidemiol 22: 173-181.
9. Botto LD, Robert-Gnansia E, Siffel C, et al. 2006. Fostering international collaboration in birth defects research and prevention: a perspective from the International Clearinghouse for Birth Defects Surveillance and Research. Am J Public Health 96: 774-780.
10. Botto LD, Yang Q. 2000. 5,10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: a HuGE review. Am J Epidemiol 151: 862-877.
11. Carmichael SL, Shaw GM, Iovannisci DM, et al. 2006a. Risks of human limb deficiency anomalies associated with 29 SNPs of genes involved in homocysteine metabolism, coagulation, cell-cell interactions, inflammatory response, and blood pressure regulation. Am J Med Genet A 140:2433-2440.
12. Carmichael SL, Shaw GM, Yang W, et al. 2006b. Risk of limb deficiency defects associated with NAT1, NAT2, GSTT1, GSTM1, and NOS3 genetic variants, maternal smoking, and vitamin supplement intake. Am J Med Genet A 140:1915-1922.
13. Carmichael SL, Shaw GM, Yang W, et al. 2004. Limb deficiency defects, MSX1, and exposure to tobacco smoke. Am J Med Genet A 125:285-289.
14. Castilla EE, Orioli IM. 2004. ECLAMC: the Latin-American collaborative study of congenital malformations. Community Genet 7:76-94.
15. Chen CL, Gilbert TJ, Daling JR. 1999. Maternal smoking and Down syndrome: the confounding effect of maternal age. Am J Epidemiol 149: 442-446.
16. Christensen K, Murray JC. 2007. What genome-wide association studies can do for medicine. N Engl J Med 356: 1094-1097.
17. Christensen K, Olsen J, Norgaard-Pedersen B, et al. 1999. Oral clefts, transforming growth factor alpha gene variants, and maternal smoking: a population-based case-control study in Denmark, 1991-1994. Am J Epidemiol 149:248-255.
18. Chung KC, Kowalski CP, Kim HM, Buchman SR. 2000. Maternal cigarette smoking during pregnancy and the risk of having a child with cleft lip/palate. Plast Reconstr Surg 105: 485-491.
19. Collier AC, Tingle MD, Paxton JW, et al. 2002. Metabolizing enzyme localization and activities in the first trimester human placenta: the effect of maternal and gestational age, smoking and alcohol consumption. Hum Reprod 17:2564-2572.
20. Cui XM, Chai Y, Chen J, et al. 2003. TGF-beta3-dependent SMAD2 phosphorylation and inhibition of MEE proliferation during palatal fusion. Dev Dyn 227:387-394.
21. Czeizel AE, Kodaj I, Lenz W. 1994. Smoking during pregnancy and congenital limb deficiency. Bmj 308: 1473-1436.
22. Fraser FC. 1970. The genetics of cleft lip and cleft palate. Am J Hum Genet 22:336-352.
23. Gato A, Martinez ML, Tudela C, et al. 2002. TGF-beta(3)-induced chondroitin sulphate proteoglycan mediates palatal shelf adhesion. Dev Biol 250:393-405.
24. Goldbaum G, Daling J, Milham S. 1990. Risk factors for gastroschisis. Teratology 42:397-403.
25. Haddow JE, Palomaki GE, Holman MS. 1993. Young maternal age and smoking during pregnancy as risk factors for gastroschisis. Teratology 47:225-228.
26. Hartsfield JK Jr, Hickman TA, Everett ET, et al. 2001. Analysis of the EPHX1 113 polymorphism and GSTM1 homozygous null polymorphism and oral clefting associated with maternal smoking. Am J Med Genet 102:21-24.
27. Hayes C. 2002. Environmental risk factors and oral clefts. Cleft lip and palate: from origin to treatment. New York, NY: Oxford University Press.
28. Henderson CJ, Smith AG, Ure J, et al. 1998. Increased skin tumorigenesis in mice lacking pi class glutathione S-transferases. Proc Natl Acad Sci USA 95:5275-5280.
29. Hines RN, McCarver DG. 2002. The ontogeny of human drug-metabolizing enzymes: phase I oxidative enzymes. J Pharmacol Exp Ther 300:355-360.
30. Hobbs CA, James SJ, Jernigan S, et al. 2006. Congenital heart defects, maternal homocysteine, smoking, and the 677 C>T polymorphism in the methylenetetrahydrofolate reductase gene: evaluating gene-environment interactions. Am J Obstet Gynecol 194:218-224.
31. Honein MA, Rasmussen SA. 2000. Further evidence for an association between maternal smoking and craniosynostosis. Teratology 62:145-146.
32. Honein MA, Rasmussen SA, Reefhuis J, et al. 2007. Maternal smoking and environmental tobacco smoke exposure and the risk of orofacial clefts. Epidemiology 18:226-233.
33. Hozyasz KK, Mostowska A, Surowiec Z, Jagodzinksi PP. 2005. [Genetic polymorphisms of GSTM1 and GSTT1 in mothers of children with isolated cleft lip with or without cleft palate]. Przegl Lek 62:1019-1022.
34. Hwang SJ, Beaty TH, Panny SR, et al. 1995. Association study of transforming growth factor alpha (TGF alpha) TaqI polymorphism and oral clefts: indication of gene-environment interaction in a population-based sample of infants with birth defects. Am J Epidemiol 141:629-636.
35. Iyer NV, Leung SW, Semenza GL. 1998. The human hypoxia-inducible factor 1alpha gene: HIF1A structure and evolutionary conservation. Genomics 52:159-165.
36. Jensen LE, Hoess K, Whitehead AS, Mitchell LE. 2005. The NAT1 C1095A polymorphism, maternal multivitamin use and smoking, and the risk of spina bifida. Birth Defects Res A Clin Mol Teratol 73:512-516.
37. Jezewski PA, Vieira AR, Nishimura C, et al. 2003. Complete sequencing shows a role for MSX1 in non-syndromic cleft lip and palate. J Med Genet 40:399-407.
38. Jugessur A, Lie RT, Wilcox AJ, et al. 2003. Cleft palate, transforming growth factor alpha gene variants, and maternal exposures: assessing gene-environment interactions in case-parent triads. Genet Epidemiol 25:367-374.
39. Jugessur A, Murray JC. 2005. Orofacial clefting: recent insights into a complex trait. Curr Opin Genet Dev 15: 270-278.
40. Jumlongras D, Bei M, Stimson JM, et al. 2001. A nonsense mutation in MSX1 causes Witkop syndrome. Am J Hum Genet 69:67-74.
41. Kallen K. 1997a. Maternal smoking and orofacial clefts. Cleft Palate-Craniofacial J 34:11-16.
42. Kallen K. 1997b. Maternal smoking during pregnancy and limb reduction malformations in Sweden. Am J Public Health 87:29-32.
43. Kallen K. 1998. Maternal smoking, body mass index, and neural tube defects. Am J Epidemiol 147:1103-1111.
44. Kallen K. 1999a. Maternal smoking and congenital heart defects. Eur J Epidemiol 15:731-737.
45. Kallen K. 1999b. Maternal smoking and craniosynostosis. Teratology 60:146-150.
46. Kallen K. 2000. Multiple malformations and maternal smoking. Paediatr Perinat Epidemiol 14:227-233.
47. Kang P, Svoboda KK. 2003. Nicotine inhibits palatal fusion and modulates nicotinic receptors and the PI-3 kinase pathway in medial edge epitheNa. Orthod Craniofac Res 6:129-142.
48. Khoury MJ, Gomez M-Farias, Mulinare J. 1989. Does maternal cigarette smoking during pregnancy cause cleft lip and palate in offspring? Am J Dis Child 143:333-337.
49. Khoury MJ, Weinstein A, Panny S, et al. 1987. Maternal cigarette smoking and oral clefts: a population-based study. Am J Public Health 77:623-625.
50. Kirby RS. 2006. Maternal cigarette smoking during pregnancy and congenital digital anomalies. Plast Reconstr Surg 118:1667-1668.
51. Lam PK, Torfs CP. 2006. Interaction between maternal smoking and malnutrition in infant risk of gastroschisis. Birth Defects Res A Clin Mol Teratol 76:182-186.
52. Lammer EJ, Shaw GM, Iovannisci DM, Finnell RH. 2005. Maternal smoking, genetic variation of glutathione s-transferases, and risk for orofacial clefts. Epidemiology 16:698-701.
53. Lammer EJ, Shaw GM, Iovannisci DM, et al. 2004. Maternal smoking and the risk of orofacial clefts: Susceptibility with NAT1 and NAT2 polymorphisms. Epidemiology 15:150-156.
54. Landi S. 2000. Mammalian class theta GST and differential susceptibility to carcinogens: a review. Mutat Res 463:247-283.
55. Lidral AC, Moreno LM. 2005. Progress toward discerning the genetics of cleft lip. Curr Opin Pediatr 17:731-739.
56. Lidral AC, Murray JC, Buetow KH, et al. 1997. Studies of the candidate genes TGFB2, MSX1, TGFA, and TGFB3 in the etiology of cleft lip and palate in the Philippines. Cleft Palate-Craniofacial J 34:1-6.
57. Lieff S OA, Werler M, Strauss RP, et al. 1999. Maternal cigarette smoking during pregnancy and risk of oral clefts in newborns. Am J Epidemiol 150:683-694.
58. Little J, Cardy A, Munger RG. 2004. Tobacco smoking and oral clefts: a meta-analysis. Bull World Health Organ 82:213-218.
59. Maestri NE, Beaty TH, Hetmanski J, et al. 1997. Application of transmission disequilibrium tests to nonsyndromic oral clefts: including candidate genes and environmental exposures in the models. Am J Med Genet 73:337-344.
60. Manolio TA, Rodriguez LL, Brooks L, et al. 2007. New models of collaboration in genome-wide association studies: the Genetic Association Information Network. Nature genetics 39:1045-1051.
61. McCarver DG, Hines RN. 2002. The ontogeny of human drug-metabolizing enzymes: phase II conjugation enzymes and regulatory mechanisms. J Pharmacol Exp Ther 300: 361-366.
62. Meyer KA, Williams P, Hernandez-Diaz S, Cnattingius S. 2004. Smoking and the risk of oral clefts: exploring the impact of study designs. Epidemiology 15:671-678.
63. Miettinen PJ, Chin JR, Shum L, et al. 1999. Epidermal growth factor receptor function is necessary for normal craniofacial development and palate closure. Nat Genet 22: 69-73.
64. Millicovsky G, Johnston MC. 1981a. Hyperoxia and hypoxia in pregnancy: simple experimental manipulation alters the incidence of cleft lip and palate in CL/Fr mice. Proc Natl Acad Sci USA 78:5722-5723.
65. Millicovsky G, Johnston MC. 1981b. Maternal hyperoxia greatly reduces the incidence of phenytoin-induced cleft lip and palate in A/J mice. Science 212:671-672.
66. Mitchell LE, Murray JC, O'Brien S, Christensen K. 2001. Evaluation of two putative susceptibility loci for oral clefts in the Danish population. Am J Epidemiol 153:1007-1015.
67. Murray JC. 2002. Gene/environment causes of cleft lip and/or palate. Clin Genet 61:248-256.
68. Nelson DR 2003. Cytochrome P450 Database, http://www.imm.ki.se/ CYPalleles/.
69. Ottman R. 1990. An epidemiologic approach to gene-environment interaction. Genet Epidemiol 7:177-185.
70. Ottman R. 1996. Gene-environment interaction: definitions and study designs. Prev Med 25:764-770.
71. Pepe G, Camacho Vanegas O, Giusti B, et al. 1998. Heterogeneity in world distribution of the thermolabile C677T mutation in 5,10-methylene- tetrahydrofolate reductase. Am J Hum Genet 63:917-920.
72. Philipp K, Pateisky N, Endler M. 1984. Effects of smoking on uteroplacental blood flow. Gynecol Obstet Invest 17:179-182.
73. Piegorsch WW, Weinberg CR, Taylor JA. 1994. Non-hierarchical logistic models and case-only designs for assessing susceptibility in population-based case-control studies. Stat Med 13:153-162.
74. Puga A, Tomlinson CR, Xia Y. 2005. Ah receptor signals cross-talk with multiple developmental pathways. Biochem Pharmacol 69:199-207.
75. Rahimov F, Hitchler MJ, Domann FE, et al. 2007.Disruption of an AP-2 binding site upstream of IRF6 is commonly associated with nonsyndromic cleft lip and palate. 57th annual meeting of the American Society of Human Genetics, San Diego, CA, USA.
76. Raijmakers MT, Steegers EA, Peters WH. 2001. Glutathione S-transferases and thiol concentrations in embryonic and early fetal tissues. Hum Reprod 16:2445-2450.
77. Ramirez D, Lammer EJ, Iovannisci DM, etal. 2007. Maternal smoking during early pregnancy, GSTP1 and EPHX1 variants, and risk of isolated orofacial clefts. Cleft Palate Craniofac J 44: 366-373.
78. Robertson IG, Guthenberg C, Mannervik B, Jernstrom B. 1986. Differences in stereoselectivity and catalytic efficiency of three human glutathione transferases in the conjugation of glutathione with 7 beta,8 alpha-dihydroxy-9 alpha, 10 alpha-oxy-7,8,9,10-tetrahydrobenzo(a)pyrene. Cancer Res 46: 2220-2224.
79. Romitti PA, Lidral AC, Munger RG, et al. 1999. Candidate genes for nonsyndromic cleft lip and palate and maternal cigarette smoking and alcohol consumption: evaluation of genotype-environment interactions from a population-based case-control study of orofacial clefts. Teratology 59:39-50.
80. Romitti PA, Sun L, Honein MA, et al. 2007. Maternal periconceptional alcohol consumption and risk of orofacial clefts. Am J Epidemiol 166: 775-785.
81. Rothman K, Greenland S. 1998. Modern epidemiology. Philadephia, PA, USA: Lippincott Williams and Wilkins.
82. Saad AY, Gartner LP, Hiatt JL. 1990. Teratogenic effects of nicotine on palate formation in mice. Biol Struct Morphog 3:31-35.
83. Saito T, Cui XM, Yamamoto T, et al. 2005. Effect of N′- nitrosonornicotine (NNN) on murine palatal fusion in vitro. Toxicology 207:475-485.
84. Schultz RE, Cooper ME, Daack-Hirsch S, et al. 2004. Targeted scan of fifteen regions for nonsyndromic cleft lip and palate in Filipino families. Am J Med Genet 125A:17-22.
85. Schwartz D, Collins F. 2007. Medicine. Environmental biology and human disease. Science 316:695-696.
86. Seller MJ, Bnait KS. 1995. Effects of tobacco smoke inhalation on the developing mouse embryo and fetus. Reprod Toxicol 9:449-459.
87. Shaw GM, Iovannisci DM, Yang W, et al. 2005a. Endothelial nitric oxide synthase (NOS3) genetic variants, maternal smoking, vitamin use, and risk of human orofacial clefts. Am J Epidemiol 162:1207-1214.
88. Shaw GM, Iovannisci DM, Yang W, et al. 2005b. Risks of human conotruncal heart defects associated with 32 single nucleotide polymorphisms of selected cardiovascular disease-related genes. Am J Med Genet A 138:21-26.
89. Shaw GM, Nelson V, Iovannisci DM, et al. 2003. Maternal occupational chemical exposures and biotransformation genotypes as risk factors for selected congenital anomalies. Am J Epidemiol 157:475-484.
90. Shaw GM, Wasserman CR, Lammer EJ, et al. 1996. Orofacial clefts, parental cigarette smoking, and transforming growth factor-alpha gene variants. Am J Hum Genet 58:551-561.
91. Shi M, Christensen K, Weinberg CR, et al. 2007. Orofacial cleft risk is increased with maternal smoking and specific detoxification-gene variants. Am J Hum Genet 80:76-90.
92. Sim E, Payton M, Noble M, Minchin R. 2000. An update on genetic, structural and functional studies of arylamine N-acetyltransferases in eucaryotes and procaryotes. Hum Mol Genet 9:2435-2441.
93. Smelt VA, Upton A, Adjaye J, et al. 2000. Expression of arylamine N-acetyltransferases in pre-term placentas and in human pre-implantation embryos. Hum Mol Genet 9: 1101-1107.
94. Stoilov I, Jansson I, Sarfarazi M, Schenkman JB. 2001. Roles of cytochrome p450 in development. Drug Metabol Drug Interact 18:33-55.
95. Suarez L, Felkner M, Brender JD, et al. 2007. Maternal exposures to cigarette smoke, alcohol, and street drugs and neural tube defect occurrence in offspring. Matern Child Health J.
96. Sun D, Vanderburg CR, Odierna GS, Hay ED. 1998. TGFbeta3 promotes transformation of chicken palate medial edge epithelium to mesenchyme in vitro. Development 125: 95-105.
97. Suzuki S, Marazita ML, Miwa N, et al. 2007. Mutations in BMP4 are associated with subepithelial, microform, and overt cleft Lip. 57th annual meeting of the American Society of Human Genetics, San Diego, CA, USA.
98. Thomae TL, Glover E, Bradfield CA. 2004. A maternal Ahr null genotype sensitizes embryos to chemical teratogenesis. J Biol Chem 279:30189-30194.
99. Thomae TL, Stevens EA, Bradfield CA. 2005. Transforming growth factor-beta3 restores fusion in palatal shelves exposed to 2,3,7,8- tetrachlorodibenzo-p-dioxin. J Biol Chem 280:12742-12746.
100. Torfs CP, Christianson RE. 1999. Maternal risk factors and major associated defects in infants with Down syndrome. Epidemiology 10:264-270.
101. Torfs CP, Christianson RE, Iovannisci DM, et al. 2006. Selected gene polymorphisms and their interaction with maternal smoking, as risk factors for gastroschisis. Birth Defects Res A Clin Mol Teratol 76: 723-730.
102. Torfs CP, Velie EM, Oechsli FW, et al. 1994. A population-based study of gastroschisis: demographic, pregnancy, and lifestyle risk factors. Teratology 50:44-53.
103. Umbach DM, Weinberg CR. 1997. Designing and analysing case-control studies to exploit independence of genotype and exposure. Stat Med 16:1731-1743.
104. Umbach DM, Weinberg CR. 2000. The use of case-parent triads to study joint effects of genotype and exposure. Am J Hum Genet 66:251-261.
105. van den Boogaard MJ, Dorland M, Beemer FA, van Amstel HK. 2000. MSX1 mutation is associated with orofacial clefting and tooth agenesis in humans. Nat Genet 24: 342-343.
106. van Rooij IA, Groenen PM, van Drongelen M, et al. 2002. Orofacial clefts and spina bifida: N-acetyltransferase phenotype, maternal smoking, and medication use. Teratology 66:260-266.
107. van Rooij IA, Wegerif MJ, Roelofs HM, et al. 2001. Smoking, genetic polymorphisms in biotransformation enzymes, and nonsyndromic oral clefting: a gene-environment interaction. Epidemiology 12:502-507.
108. Vieira AR. 2006. Association between the transforming growth factor alpha gene and nonsyndromic oral clefts: a HuGE review. Am J Epidemiol 163: 790-810.
109. Vieira AR, Orioli IM, Castilla EE, et al. 2003. MSX1 and TGFB3 contribute to clefting in South America. J Dent Res 82:289-292.
110. Warkany J, Nelson RC, Schraffenberger E. 1943. Congenital malformations induced in rats by maternal nutritional deficiency. Am J Dis Child 65:882-894.
111. Wasserman CR, Shaw GM, O'Malley CD, et al. 1996. Parental cigarette smoking and risk for congenital anomalies of the heart, neural tube, or limb. Teratology 53:261-267.
112. Watson MA, Stewart RK, Smith GB, et al. 1998. Human glutathione S-transferase P1 polymorphisms: relationship to lung tissue enzyme activity and population frequency distribution. Carcinogenesis 19:275-280.
113. Wehby GL, Marcinow A, Quin X, et al. 2007. A genetic instrumental variables analysis of the effects of maternal smoking on oral cleft risks. 57th annual meeting of the American Society of Human Genetics, San Diego, CA, USA.
114. Weinberg CR. 2007. Can DAGs clarify effect modification? Epidemiology 18:569-572.
115. Werler MM, Lammer EJ, Rosenberg L, Mitchell AA. 1990. Maternal cigarette smoking during pregnancy in relation to oral clefts. Am J Epidemiol 132: 926-932.
116. Werler MM, Mitchell AA, Shapiro S. 1992. Demographic, reproductive, medical, and environmental factors in relation to gastroschisis. Teratology 45:353-360.
117. Whitlock JP Jr. 1999. Induction of cytochrome P4501A1. Annu Rev Pharmacol Toxicol 39:103-125.
118. Wyszynski DF, Duffy DL, Beaty TH. 1997. Maternal cigarette smoking and oral clefts: a meta-analysis. Cleft Palate Craniofac J 34:206-210.
119. Wyszynski DF, Wu T. 2002. Use of US birth certificate data to estimate the risk of maternal cigarette smoking for oral clefting. Cleft Palate Craniofac J 39:188-192.
120. Yazdy MM, Honein MA, Rasmussen SA, Frias JL. 2007. Priorities for future public health research in orofacial clefts. Cleft Palate Craniofac J 44: 351-357.
121. Yoon P, Rasmussen LM SA, Moore CA, et al. 2001. The National Birth Defects Prevention Study. Public Health Reports 116(Suppl 1):32.
122. Zeiger JS, Beaty TH, Hetmanski JB, etal. 2002. Genetic and environmental risk factors for sagittal craniosynostosis. J Craniofac Surg 13:602-606.
123. Zeiger JS, Beaty TH, Liang KY. 2005. Oral clefts, maternal smoking, and TGFA: a meta-analysis of gene-environment interaction. Cleft Palate Craniofac J 42:58-63.